Arcus Biosciences's market cap is currently $1.00B. The company's EPS TTM is $-3.153; its P/E ratio is ―; Arcus Biosciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 117.00M	$ 112.00M	$ 382.88M	$ 77.52M	$ 15.00M
Gross Profit	$ -223.00M	$ 98.00M	$ 375.82M	$ -81.48M	$ -63.48M
Operating Income	$ -340.00M	$ -280.00M	$ 54.25M	$ -124.23M	$ -88.71M
EBITDA	$ -283.00M	$ -250.00M	$ 61.96M	$ -118.47M	$ -81.13M
Net Income	$ -307.00M	$ -267.00M	$ 53.00M	$ -116.68M	$ -75.93M
Balance Sheet
Cash & Short-Term Investments	$ 759.00M	$ 1.14B	$ 681.30M	$ 735.09M	$ 188.27M
Total Assets	$ 1.09B	$ 1.34B	$ 1.59B	$ 772.29M	$ 203.11M
Total Debt	$ 11.00M	$ 120.00M	$ 116.89M	$ 15.24M	$ 0.00
Net Debt	$ -116.00M	$ -86.00M	$ -31.03M	$ -158.17M	$ -57.94M
Total Liabilities	$ 633.00M	$ 688.00M	$ 750.45M	$ 269.99M	$ 39.27M
Stockholders' Equity	$ 462.00M	$ 657.00M	$ 841.45M	$ 502.30M	$ 163.84M
Cash Flow
Free Cash Flow	$ -330.00M	$ 426.00M	$ -282.25M	$ 108.11M	$ -75.39M
Operating Cash Flow	$ -306.00M	$ 438.00M	$ -256.17M	$ 111.17M	$ -73.46M
Investing Cash Flow	$ 194.00M	$ -413.00M	$ -3.87M	$ -434.37M	$ 59.21M
Financing Cash Flow	$ 33.00M	$ 33.00M	$ 237.34M	$ 438.68M	$ 1.12M

Currency in USD

Arcus Biosciences Earnings and Revenue History

Income Statement >

Arcus Biosciences Debt to Assets

Balance Sheet >

Arcus Biosciences Cash Flow

Cash Flow >

Arcus Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing